Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HPPI
HedgePath Pharmaceuticals
$0.06
$0.05
$0.04
$0.32
$32.16M-1.1619,283 shs6,000 shs
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
$0.36
+11.0%
$0.34
$0.25
$0.48
$33.15M1.48913,992 shs214,616 shs
Integrated BioPharma Inc. stock logo
INBP
Integrated BioPharma
$0.26
$0.31
$0.17
$0.42
$8.13M0.89,327 shsN/A
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
$2.94
+1.4%
$3.23
$1.19
$10.00
$27.76MN/A47,397 shs80,384 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HPPI
HedgePath Pharmaceuticals
+12.32%+44.75%+5.85%-1.70%-20.66%
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
0.00%-1.63%-3.72%+7.74%-8.01%
Integrated BioPharma Inc. stock logo
INBP
Integrated BioPharma
0.00%-1.43%-7.99%-20.69%+31.25%
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
0.00%-14.29%-25.94%+50.00%+9,700.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
HPPI
HedgePath Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
1.7575 of 5 stars
3.50.00.00.01.81.70.0
Integrated BioPharma Inc. stock logo
INBP
Integrated BioPharma
N/AN/AN/AN/AN/AN/AN/AN/A
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
4.3674 of 5 stars
3.80.00.00.02.83.33.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
HPPI
HedgePath Pharmaceuticals
0.00
N/AN/AN/A
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
3.00
Buy$3.88970.44% Upside
Integrated BioPharma Inc. stock logo
INBP
Integrated BioPharma
0.00
N/AN/AN/A
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
3.50
Strong Buy$10.00240.14% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
HPPI
HedgePath Pharmaceuticals
N/AN/AN/AN/A($0.01) per shareN/A
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
$1.33M24.77N/AN/A$0.08 per share4.53
Integrated BioPharma Inc. stock logo
INBP
Integrated BioPharma
$50.32M0.16$0.04 per share5.93$0.64 per share0.41
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
$34.83M0.80$0.27 per share11.05($1.31) per share-2.24
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
HPPI
HedgePath Pharmaceuticals
-$4.55MN/A0.00N/AN/AN/A-246.03%N/A
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
-$13M-$0.07N/AN/AN/A-714.16%-122.44%-88.40%N/A
Integrated BioPharma Inc. stock logo
INBP
Integrated BioPharma
$110K$0.046.56N/A2.37%6.36%4.84%9/18/2025 (Estimated)
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
$2.12M$0.387.744.98N/A10.02%-18.56%20.28%N/A

Latest INBP, SNYR, IGC, and HPPI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
$0.08$0.17+$0.09$0.17$10.80 million$6.74 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
HPPI
HedgePath Pharmaceuticals
N/AN/AN/AN/AN/A
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
N/AN/AN/AN/AN/A
Integrated BioPharma Inc. stock logo
INBP
Integrated BioPharma
N/AN/AN/AN/AN/A
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
HPPI
HedgePath Pharmaceuticals
N/A
6.76
6.76
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
0.02
1.15
0.98
Integrated BioPharma Inc. stock logo
INBP
Integrated BioPharma
N/A
3.72
1.70
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
N/A
2.74
1.62

Institutional Ownership

CompanyInstitutional Ownership
HPPI
HedgePath Pharmaceuticals
N/A
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
3.87%
Integrated BioPharma Inc. stock logo
INBP
Integrated BioPharma
25.25%
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
N/A

Insider Ownership

CompanyInsider Ownership
HPPI
HedgePath Pharmaceuticals
4.80%
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
31.48%
Integrated BioPharma Inc. stock logo
INBP
Integrated BioPharma
67.20%
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
56.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
HPPI
HedgePath Pharmaceuticals
1370.45 millionN/ANot Optionable
IGC Pharma, Inc. stock logo
IGC
IGC Pharma
6190.81 million54.60 millionN/A
Integrated BioPharma Inc. stock logo
INBP
Integrated BioPharma
15030.98 million10.16 millionNot Optionable
Synergy CHC Corp. stock logo
SNYR
Synergy CHC
409.44 million4.10 millionN/A

Recent News About These Companies

Synergy CHC's (NASDAQ:SNYR) Earnings Quality Is Low
Synergy CHC Corp to Present at the 2025 Gateway Conference on September 4th
Analysts Set Expectations for Synergy CHC FY2025 Earnings
Synergy Chc EPS Jumps 86 Percent in Q2
Jack Ross Buys Handful Of Shares In Synergy CHC

New MarketBeat Followers Over Time

Media Sentiment Over Time

HedgePath Pharmaceuticals OTCMKTS:HPPI

$0.06 0.00 (0.00%)
As of 08/22/2025

HedgePath Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for patients with cancers and non-cancerous proliferation disorders in the United States. It primarily focuses on the development of therapies for skin, lung, and prostate cancers. The company's Hedgehog signaling pathway is a primary regulator of cellular processes in vertebrates, including stem cell maintenance, cell differentiation, tissue polarity, and cell proliferation. It also develops super bioavailability (SUBA)-itraconazole oral capsules for patients with basal cell carcinoma nevus syndrome. SUBA-Itraconazole is a patented itraconazole formulation that enhances the absorption of itraconazole to enhance the bioavailability of orally administered drugs that are poorly soluble. The company was founded in 1992 and is headquartered in Tampa, Florida. HedgePath Pharmaceuticals, Inc. is a subsidiary of Mayne Pharma Ventures Pty Ltd.

IGC Pharma stock logo

IGC Pharma NYSEMKT:IGC

$0.36 +0.04 (+11.01%)
Closing price 08/22/2025 03:58 PM Eastern
Extended Trading
$0.36 0.00 (-0.83%)
As of 08/22/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.

Integrated BioPharma stock logo

Integrated BioPharma OTCMKTS:INBP

$0.26 0.00 (0.00%)
As of 08/22/2025

Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

Synergy CHC stock logo

Synergy CHC NASDAQ:SNYR

$2.94 +0.04 (+1.38%)
As of 08/22/2025 04:00 PM Eastern

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.